Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution

Phillip Scheinberg, Danielle Townsley, Bogdan Dumitriu, Priscila Scheinberg, Barbara Weinstein, Maithili Daphtary, Olga Rios, Colin O. Wu, Neal S. Young

Blood (2014) 124 (18): 2820–2823.

https://doi.org/10.1182/blood-2014-05-573642

Published: 2014

Includes: Supplemental data

Journal Articles

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

Phillip Scheinberg, Olga Nunez, Barbara Weinstein, Priscila Scheinberg, Colin O. Wu, Neal S. Young

Blood (2012) 119 (2): 345–354.

https://doi.org/10.1182/blood-2011-05-352328

Published: 2012

Includes: Supplemental data

Journal Articles

Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia

Phillip Scheinberg, MD, Olga Nunez, RN, Priscila Scheinberg, MS, CCRP, Barbara Weinstein, RN, Colin O. Wu, PhD, Neal S. Young, MD

Blood (2011) 118 (21): 2406.

https://doi.org/10.1182/blood.V118.21.2406.2406

Published: 2011

Journal Articles

A Randomized Trial of Horse Versus Rabbit Antithymocyte Globulin In Severe Acquired Aplastic Anemia

Phillip Scheinberg, MD, Colin O Wu, PhD, Priscila Scheinberg, MS, Barbara Weinstein, RN, Olga Nunez, RN, Elaine M Sloand, MD, Neal S. Young, MD

Blood (2010) 116 (21): LBA-4.

https://doi.org/10.1182/blood.V116.21.LBA-4.LBA-4

Published: 2010

Journal Articles

Alemtuzumab (Campath) Monotherapy for Severe Aplastic Anemia.

Phillip Scheinberg, MD, Colin O Wu, PhD, Priscila Scheinberg, MS, CCRP, Olga Nunez, RN, Elaine M Sloand, MD, Neal S. Young, MD

Blood (2010) 116 (21): 1167.

https://doi.org/10.1182/blood.V116.21.1167.1167

Published: 2010

Journal Articles

Inflammatory Cytokine Levels in the Peri-Stem Cell Transplantation Period Correlate with Fluctuations in Peripheral Blood Counts but Not with Inflammation.

J. Joseph Melenhorst, PhD, Angelique Biancotto, PhD, Phillip Scheinberg, MD, Colin O. Wu, PhD, J. Philip McCoy, PhD, Priscila Scheinberg, Nancy F Hensel, A. John Barrett, MD, FRCP

Blood (2008) 112 (11): 1541.

https://doi.org/10.1182/blood.V112.11.1541.1541

Published: 2008

NARROW

Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia

A Randomized Trial of Horse Versus Rabbit Antithymocyte Globulin In Severe Acquired Aplastic Anemia

Alemtuzumab (Campath) Monotherapy for Severe Aplastic Anemia.

Inflammatory Cytokine Levels in the Peri-Stem Cell Transplantation Period Correlate with Fluctuations in Peripheral Blood Counts but Not with Inflammation.

Email alerts

ASH Publications

American Society of Hematology

Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia

A Randomized Trial of Horse Versus Rabbit Antithymocyte Globulin In Severe Acquired Aplastic Anemia

Alemtuzumab (Campath) Monotherapy for Severe Aplastic Anemia.

Inflammatory Cytokine Levels in the Peri-Stem Cell Transplantation Period Correlate with Fluctuations in Peripheral Blood Counts but Not with Inflammation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only